X
Record #23832

Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea

Journal
medRxiv
Original paper date
May 18, 2020
Institution
Korea University, College of Medicine, Seoul, Republic of Korea · Busan University, School of Medicine, Busan, Republic of Korea · Korea Workers’ Compensation & Welfare Services Daegu Hospital, 515 Hakjeong-ro, Bukgu, Daegu, Republic of Korea · So Ahn Public Health Center, Wando, Republic of Korea · Cheongsan Public Health Center, Wando, Republic of Korea · Bukha Public Health Center, Jangseong, Republic of Korea · Department of Pharmacology, Pusan National University, School of Medicine, Yangsan, Republic of Korea · Gene and Cell Therapy Research Center for Vessel-associated Diseases, School of Medicine, Pusan National University, Yangsan, Republic of Korea · Department of Urology, Korea University, School of Medicine, Seoul, Republic of Korea · Ajou University, School of Medicine, Suwon, Republic of Korea
Open access
No
Article type
Preprint · Research Article
Broad categories
(HSC) Medicine - Infectious Disease(HSC) Medicine - Pharmacology
Citation lifecycle

How this paper is being cited

Pre-retraction
2
Same day
0
Post-retraction
11
% post-retraction
84.6%
~27.1 citations/yr before retraction · ~1.8 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse